Phase I and pharmacologic study of i.p. 9-aminocamptothecin given as six fractions over 14 days.
Muggia FM, Liebes L, Hazarika M, Wadler S, Hamilton A, Hornreich G, Sorich J, Chiang C, Newman E, Potmesil M, Hochster H.
Muggia FM, et al. Among authors: sorich j.
Anticancer Drugs. 2002 Sep;13(8):819-25. doi: 10.1097/00001813-200209000-00006.
Anticancer Drugs. 2002.
PMID: 12394266
Clinical Trial.